Adverse outcomes among Aboriginal patients receiving peritoneal dialysis

被引:19
|
作者
Sood, Manish M. [1 ]
Komenda, Paul [2 ]
Sood, Amy R. [3 ]
Reslerova, Martina [2 ]
Verrelli, Mauro [2 ]
Sathianathan, Chris [2 ]
Eng, Loretta [2 ]
Eng, Amanda [2 ]
Rigatto, Claudio [4 ]
机构
[1] St Boniface Gen Hosp, Dept Med, Winnipeg, MB R3X 1Y2, Canada
[2] St Boniface Gen Hosp, Dept Nephrol, Winnipeg, MB R3X 1Y2, Canada
[3] St Boniface Gen Hosp, Dept Pharm, Winnipeg, MB R3X 1Y2, Canada
[4] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; STAGE RENAL-DISEASE; 1ST NATIONS PEOPLE; HEMODIALYSIS; PREDICTORS; AUSTRALIA; MORTALITY; RISK; PREVALENCE; CANADIANS;
D O I
10.1503/cmaj.100105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Aboriginal population in Canada experiences high rates of end-stage renal disease and need for dialytic therapies. Our objective was to examine rates of mortality, technique failure and peritonitis among adult aboriginal patients receiving peritoneal dialysis in the province of Manitoba. We also aimed to explore whether differences in these rates may be accounted for by location of residence (i.e., urban versus rural). Methods: We included all adult patients residing in the province of Manitoba who received peritoneal dialysis during the period from 1997-2007 (n = 727). We extracted data from a local administrative database and from the Canadian Organ Replacement Registry and the Peritonitis Organism Exit-sites/Tunnel infections (POET) database. We used Cox and logistic regression models to determine the relationship between outcomes and Aboriginal ethnicity. We performed Kaplan-Meier analyses to examine the relationship between outcomes and urban (i.e., 50 km or less from the primary dialysis centre in Winnipeg) versus rural (i.e., more than 50 km from the centre) residency among patients who were aboriginal. Results: One hundred sixty-one Aboriginal and 566 non-Aboriginal patients were included in the analyses. Adjusted hazard ratios for mortality (HR 1.476, CI 1.073-2.030) and adjusted time to peritonitis (HR 1.785, CI 1.352-2.357) were significantly higher among Aboriginal patients than among non-Aboriginal patients. We found no significant differences in mortality, technique failure or peritonitis between urban-or rural-residing Aboriginal patients. Interpretation: Compared with non-Aboriginal patients receiving peritoneal dialysis, Aboriginal patients receiving peritoneal dialysis had higher mortality and faster time to peritonitis independent of comorbidities and demographic characteristics. This effect was not influenced by place of residence, whether rural or urban.
引用
收藏
页码:1433 / 1439
页数:7
相关论文
共 50 条
  • [31] Low Mitochondrial DNA Copy Number is Associated With Adverse Clinical Outcomes in Peritoneal Dialysis Patients
    Yoon, Chang-Yun
    Park, Jung Tak
    Kee, Youn Kyung
    Han, Seung Gyu
    Han, In Mee
    Kwon, Young Eun
    Park, Kyoung Sook
    Lee, Mi Jung
    Han, Seung Hyeok
    Kang, Shin-Wook
    Yoo, Tae-Hyun
    MEDICINE, 2016, 95 (07) : e2717
  • [32] Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
    You, Xiaohan
    Zhou, Ying
    Zhang, Jianna
    Zhou, Qiongxiu
    Shi, Yanling
    Su, Zhen
    Chen, Chaoshen
    Shao, Rongrong
    Zhang, Ji
    BMC NEPHROLOGY, 2020, 21 (01)
  • [33] Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry
    Keia R. Sanderson
    Yichun Yu
    Hongying Dai
    Laurel K. Willig
    Bradley A. Warady
    Pediatric Nephrology, 2019, 34 : 155 - 162
  • [34] Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis
    Xiaohan You
    Ying Zhou
    Jianna Zhang
    Qiongxiu Zhou
    Yanling Shi
    Zhen Su
    Chaoshen Chen
    Rongrong Shao
    Ji Zhang
    BMC Nephrology, 21
  • [35] Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry
    Sanderson, Keia R.
    Yu, Yichun
    Dai, Hongying
    Willig, Laurel K.
    Warady, Bradley A.
    PEDIATRIC NEPHROLOGY, 2019, 34 (01) : 155 - 162
  • [36] PERITONEAL LEUKOCYTE RESPONSE TO BACTERIAL PERITONITIS IN PATIENTS RECEIVING PERITONEAL-DIALYSIS
    SHAH, GM
    SABO, A
    WINER, RL
    ROSS, EA
    KIRSCHENBAUM, MA
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1990, 13 (01): : 44 - 50
  • [37] Establishing a core outcome measure for life participation in patients receiving peritoneal dialysis: A Standardised Outcomes in Nephrology-Peritoneal Dialysis consensus workshop report
    Cheetham, Melissa S.
    Wilkie, Martin
    Loud, Fiona
    Manera, Karine E.
    Ju, Angela
    Figueiredo, Ana
    Farragher, Janine
    Hurst, Helen
    Jassal, Sarbjit, V
    Mehrotra, Rajnish
    Morton, Rachael L.
    Schwartz, Daniel
    Shen, Jenny, I
    Walker, Rachael
    Cho, Yeoungjee
    Johnson, David W.
    Craig, Jonathan C.
    Anumudu, Samaya
    Baumgart, Amanda
    Gonzalez, Andrea Matus
    Scholes-Robertson, Nicole
    Viecelli, Andrea K.
    Tong, Allison
    PERITONEAL DIALYSIS INTERNATIONAL, 2022, 42 (06): : 562 - 570
  • [38] PERITONEAL DIALYSIS RELATED OUTCOMES IN OBESE PATIENTS
    Ahmad, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 664 - 665
  • [39] PREDICTIVE FACTORS FOR ADVERSE OUTCOMES OF EXIT SIDE INFECTIONS IN PERITONEAL DIALYSIS
    Filipa, Silva
    Tavares, Joana
    Castro, Ana
    Correia, Sofia
    Moreira, Carla
    Oliveira, Joao
    Santos, Olivia
    Malheiro, Jorge
    Carvalho, Maria Joao
    Rodrigues, Anabela
    Cabrita, Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [40] OUTCOMES OF OLDER PATIENTS RECEIVING CHRONIC DIALYSIS
    KUTNER, NG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (04): : 274 - 275